Acute 'binge' cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system

Brain Research Bulletin

Volumn 48, Issue 1, 1999, Pages 109-112

  Yuferov, Vadim ^a   Zhou, Yan ^a   Spangler, Rudolph ^a   Maggos, Christopher E ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Amygdala; Caudate putamen; Frontal cortex; Nucleus accumbens; Solution hybridization RNase protection assay

Indexed keywords

COCAINE; MESSENGER RNA; MU OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BASOLATERAL MEMBRANE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; LIMBIC CORTEX; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REINFORCEMENT;

EID: 0032943001     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00155-5     Document Type: Article

References (34)

1. Azaryan A.V., Clock B.J., Cox B.M. Transient upregulation of mu opioid receptor mRNA in nucleus accumbens during chronic cocaine administration. FASEB J. 10:1996;A448.
2. Azaryan A.V., Coughlin L.J., Buzas B., Clock B.J., Cox B.M. Effect of chronic cocaine treatment on μ- and δ-opioid receptor mRNA levels in dopaminergically innervated brain regions. J. Neurochem. 66:1996;443-448.
3. Branch A.D., Unterwald E.M., Lee S.E., Kreek M.J. Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol. Brain Res. 14:1992;231-238.
4. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653-661.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
6. Chou H., Ogawa N., Asanuma M., Hirata H., Kondo Y., Mori A. Rapid response of striatal M1-receptor mRNA to muscarinic cholinergic agents in rat brain. Mol. Brain Res. 19:1993;211-214.
7. 2-adrenergic receptor gene in response to short-term agonist exposure. Proc. Natl. Acad. Sci. USA. 86:1989;4853-4857.
8. Daunais J.B., McGinty J.F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Mol. Brain Res. 29:1995;201-210.
9. Daunais J.B., Roberts D.C., McGinty J.F. Cocaine self-administration increases preprodynorphin, but not c- fos, mRNA in rat striatum. Neuroreport. 4:1993;543-546.
10. Delfs J.M., Kong H., Mestek A., Chen Y., Yu L., Reisine T., Chesselet M.F. Expression of mu opioid receptor mRNA in rat brain An in situ hybridization study at the single cell level . J. Comp. Neurol. 345:1994;46-68.
11. Hammer R.P. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse. 3:1989;55-60.
12. 1- adrenergic receptor mRNA and gene transcription in rat C6 glioma cells. J. Neurochemistry. 63:1994;1635-1645.
13. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13:1992;165-170.
14. 3H-naloxone binding in brain membranes isolated from spontaneously hyperactive and Wistar-Kyoto rats. Life Sci. 43:1988;2275-2282.
15. Keith D.E., Murray S.R., Zaki P., Chu P.C., Lissin D.V., Kang L., Evans C.J., Von Zastrov M. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271:1996;19021-19024.
16. Li S.J., Sivam S.P., Jiang H.K., Douglass J., Calaveta L., Hong J.S. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharm. Exp. Ther. 246:1988;403-408.
17. Maisonneuve I.M., Kreek M.J. Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats An in vivo microdialysis study . J. Pharm. Exp. Ther. 268:1994;916-921.
18. 2-adrenergic receptor and its mRNA in the rat lung by dexamethasone. Exp. Lung Res. 21:1995;535-546.
19. Pak Y., Kouvelas A., Scheideler M.R., Rasmussen J., O'Doud B., George S.R. Agonist-induced functional desensitization of the μ-opioid receptor is mediated by loss of membrane receptor rather than uncoupling from G protein. Mol. Pharmacol. 50:1996;1214-1222.
20. Post R.M. Intermittent versus continuous stimulation Effect of time interval on the development of sensitization or tolerance . Life Sci. 26:1980;1275-1282.
21. Sivam S.P. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp. Ther. 250:1989;818-824.
22. Smiley P.L., Johnson M., Bush L., Gibb J.W., Hanson G.R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253:1990;938-943.
23. Spangler R., Unterwald E.M., Kreek M.J. "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19:1993;323-327.
24. Spangler R., Ho A., Zhou Y., Maggos C.E., Yuferov V., Kreek M.J. Regulation of kappa opioid receptor mRNA in the rat brain by binge pattern cocaine administration and correlation with preprodynorphin mRNA. Mol. Brain Res. 38:1996;71-76.
25. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., Kreek M.J. Dopamine antagonist and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs. Neuroreport. 7:1996;2196-2200.
26. Spangler R., Zhou Y., Maggos C.E., Schlussman S.D., Ho A., Kreek M.J. Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute "binge" cocaine. Mol. Brain Res. 44:1997;139-142.
27. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
28. 5]-enlkephalin and neurotensin content in the rat. Biochem. Pharmacol. 41:1991;1385-1391.
29. Torres G., Rivier C. Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression. Brain Res. 571:1992;204-211.
30. Trujillo K.A., Day R., Akil H. Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Brain Res. 518:1990;244-256.
31. Unterwald E.M., Horne-King J., Kreek M.J. Chronic cocaine alters brain mu opioid receptors. Brain Res. 584:1992;314-318.
32. Unterwald E.M., Rubenfeld J.M., Kreek M.J. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 5:1994;1613-1616.
33. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19:1996;319-340.
34. Zubieta J.K., Gorelick D.A., Stauffer R., Ravert H.T., Dannals R.F., Frost J.J. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nature Med. 2:1996;1225-1229.